Mettler-Toledo International Inc. (MTD) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 51.38M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $51.38M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $66.89M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $69.06M | (m) | (m) |
| 2025-06-30 | (m) | (m) | $61.83M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $59.36M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $71.57M | (m) | (m) |
| 2024-06-30 | (m) | (m) | $70.81M | (m) | (m) |
| 2023-12-31 | (m) | (m) | $69.81M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $69.67M | (m) | (m) |
| 2023-06-30 | (m) | (m) | $83.57M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $95.97M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $122.14M | (m) | (m) |
| 2022-06-30 | (m) | (m) | $109.45M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $98.56M | (m) | (m) |
| 2021-09-30 | (m) | (m) | $183.67M | (m) | (m) |
| 2021-06-30 | (m) | (m) | $142.25M | (m) | (m) |
| 2021-03-31 | (m) | (m) | $106.65M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $94.25M | (m) | (m) |
| 2020-09-30 | (m) | (m) | $153.69M | (m) | (m) |
| 2020-06-30 | (m) | (m) | $127.28M | (m) | (m) |
| 2020-03-31 | (m) | (m) | $323.58M | (m) | (m) |
| 2019-12-31 | (m) | (m) | $207.78M | (m) | (m) |
| 2019-09-30 | (m) | (m) | $120.53M | (m) | (m) |
| 2019-06-30 | (m) | (m) | $124.44M | (m) | (m) |
| 2019-03-31 | (m) | (m) | $126.48M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $178.11M | (m) | (m) |
| 2018-09-30 | (m) | (m) | $137.45M | (m) | (m) |
| 2018-06-30 | (m) | (m) | $183.19M | (m) | (m) |
| 2018-03-31 | (m) | (m) | $98.95M | (m) | (m) |
| 2017-12-31 | (m) | (m) | $148.69M | (m) | (m) |
| 2017-09-30 | (m) | (m) | $169.09M | (m) | (m) |
| 2017-06-30 | (m) | (m) | $146.33M | (m) | (m) |
| 2017-03-31 | (m) | (m) | $164.89M | (m) | (m) |
| 2016-12-31 | (m) | (m) | $158.67M | (m) | (m) |
| 2016-09-30 | (m) | (m) | $146.13M | (m) | (m) |
| 2016-06-30 | (m) | (m) | $114.65M | (m) | (m) |
| 2016-03-31 | (m) | (m) | $110.59M | (m) | (m) |
| 2015-12-31 | (m) | (m) | $98.89M | (m) | (m) |
| 2015-09-30 | (m) | (m) | $123.30M | (m) | (m) |
| 2015-06-30 | (m) | (m) | $149.31M | (m) | (m) |
| 2015-03-31 | (m) | (m) | $75.36M | (m) | (m) |
| 2014-12-31 | (m) | (m) | $85.26M | (m) | (m) |
| 2014-09-30 | (m) | (m) | $126.31M | (m) | (m) |
| 2014-06-30 | (m) | (m) | $111.01M | (m) | (m) |
| 2014-03-31 | (m) | (m) | $115.80M | (m) | (m) |
| 2013-12-31 | (m) | (m) | $111.87M | (m) | (m) |
| 2013-09-30 | (m) | (m) | $92.22M | (m) | (m) |
| 2013-06-30 | (m) | (m) | $120.22M | (m) | (m) |
| 2013-03-31 | (m) | (m) | $93.21M | (m) | (m) |
| 2012-12-31 | (m) | (m) | $101.70M | (m) | (m) |
| 2012-09-30 | (m) | (m) | $105.37M | (m) | (m) |
| 2012-06-30 | (m) | (m) | $134.77M | (m) | (m) |
| 2012-03-31 | (m) | (m) | $156.19M | (m) | (m) |
| 2011-12-31 | (m) | (m) | $235.60M | (m) | (m) |
| 2011-09-30 | (m) | (m) | $262.47M | (m) | (m) |
| 2011-06-30 | (m) | (m) | $328.76M | (m) | (m) |
| 2011-03-31 | (m) | (m) | $388.10M | (m) | (m) |
| 2010-12-31 | (m) | (m) | $447.58M | (m) | (m) |
| 2010-09-30 | (m) | (m) | $142.88M | (m) | (m) |
| 2010-06-30 | (m) | (m) | $111.59M | (m) | (m) |
| 2010-03-31 | (m) | (m) | $85.88M | (m) | (m) |
| 2009-12-31 | (m) | (m) | $85.03M | (m) | (m) |
| 2009-09-30 | (m) | (m) | $113.95M | (m) | (m) |
| 2009-06-30 | (m) | (m) | $119.73M | (m) | (m) |
| 2008-12-31 | (m) | (m) | $78.07M | (m) | (m) |
| 2007-12-31 | (m) | (m) | $81.22M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |